Literature DB >> 13174662

Studies on hydralazine; evidence for a peripheral site of action.

A STUNKARD, L WERTHEIMER, W REDISCH.   

Abstract

Entities:  

Keywords:  SYMPATHOLYTICS/effects

Mesh：

Substances：

Year:  1954        PMID： 13174662      PMCID： PMC438540          DOI： 10.1172/JCI102972

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Comparison of various vascular beds in man; their responses to a simple vasodilator stimulus.

Authors:  W REDISCH; L WERTHEIMER; C DELISLE; J M STEELE
Journal:  Circulation       Date:  1954-01       Impact factor: 29.690

2.  Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).

Authors:  E L WILKINSON; H BACKMAN; H H HECHT
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

3.  Skin temperature response of normal human subjects to various conditions.

Authors:  W REDISCH; E SHECKMAN; J M STELLE
Journal:  Circulation       Date:  1952-12       Impact factor: 29.690

4.  THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN.

Authors:  H Chasis; H A Ranges; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1938-09       Impact factor: 14.808

5.  Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response.

Authors:  J H MOYER; C A HANDLEY; R A HUGGINS
Journal:  J Pharmacol Exp Ther       Date:  1951-12       Impact factor: 4.030

6.  The effect of 1-hydrasinophthalasine in hypertension.

Authors:  N A SCHROEDER
Journal:  Circulation       Date:  1952-01       Impact factor: 29.690

7.  A hormonal neurogenic vasopressor mechanism.

Authors:  R D TAYLOR; I H PAGE; A C CORCORAN
Journal:  AMA Arch Intern Med       Date:  1951-07

8.  Neurogenic hypertension; chemical approaches to its amelioration.

Authors:  F F YONKMAN
Journal:  J Mich State Med Soc       Date:  1951-02

9.  The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man.

Authors:  E D FREIS; J C MacKAY; W F OLIVER
Journal:  Circulation       Date:  1951-02       Impact factor: 29.690

10.  Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968).

Authors:  E D FREIS; F A FINNERTY
Journal:  Proc Soc Exp Biol Med       Date:  1950-10
View more
  12 in total

1.  [Effect of peroral prolonged therapy with 1,4-dihydrazinophthalazine on circulation and reflex changes in dogs].

Authors:  V EHRLICH; K FRONKOVA; L SLEGR
Journal:  Arch Kreislaufforsch       Date:  1958-09

2.  Significant clinical variations in hypertension.

Authors:  M J MOSELY
Journal:  J Natl Med Assoc       Date:  1955-07       Impact factor: 1.798

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

4.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

5.  The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.

Authors:  B M Johnson
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

6.  Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide.

Authors:  J Koch-Weser
Journal:  Experientia       Date:  1974-02-15

7.  Mechanism of action of hydralazine and ISF 2123 on arterial smooth muscle [proceedings].

Authors:  M Worcel
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

8.  Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in noradrenergic neurotransmission in the conscious rat.

Authors:  R M Graham; W H Stephenson; W A Pettinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

9.  Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.

Authors:  J Mehta; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1978-08

10.  Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.

Authors:  W R Ginks; D R Redwood
Journal:  Br Heart J       Date:  1980-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.